11:36 EDT Ambrx Biopharma trading resumes
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on AMAM:
- Ambrx Biopharma reports safety, efficacy data from Phase 1/2 APEX-01 trial
- Ambrx Provides Safety and Efficacy Data from Ongoing Phase 1/2 APEX-01 Trial of ARX517 in mCRPC at ESMO Congress
- Ambrx to Host KOL Event Discussing ARX517 Data Presented at ESMO Congress 2023
- Ambrx Biopharma initiated with an Outperform at JMP Securities
- Insider Trading: Ambrx Stock (NASDAQ:AMAM) Gains on Huge Insider Buy